SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE : revenue, balance sheet and financial ratios

SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTARGIS (45200), this company of category PME shows in 2023 a revenue of 10.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE (SIREN 797450947)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 10 359 884 € 10 501 717 € 6 412 772 € 9 499 481 € 9 268 590 € 9 219 384 € 8 801 280 € 8 459 132 €
Net income 560 659 € 352 589 € 673 099 € 405 973 € 597 992 € 443 189 € 481 631 € 506 731 € 466 254 €
EBITDA N/C 823 298 € 1 077 299 € 510 645 € 796 069 € 769 647 € 766 319 € 883 849 € 966 582 €
Net margin N/C 3.4% 6.4% 6.3% 6.3% 4.8% 5.2% 5.8% 5.5%

Revenue and income statement

In 2024, SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE generates positive net income of 561 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 466 k€ -> 561 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

560 659 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 802%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 9%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

802.437%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

9.412%

Solvency indicators evolution
SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE

Sector positioning

Debt ratio
802.44 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of SELAS PHARMACIE DU CENTRE... (802.44) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
9.41% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of SELAS PHARMACIE DU CENTRE... (9.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
13.16 years 2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Watch

In 2023, the repayment capacity of SELAS PHARMACIE DU CENTRE... (13.16) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE

Positioning of SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE is estimated at 7 827 214 € (range 5 450 748€ - 11 709 960€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
5450k€ 7827k€ 11709k€
7 827 214 € Range: 5 450 748€ - 11 709 960€
NAF 5 année 2024

Valuation method used

Net Income Multiple
560 659 € × 14.0x = 7 827 214 €
Range: 5 450 748€ - 11 709 960€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE

What is the revenue of SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE ?

The revenue of SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE in 2023 is 10.4 M€.

Is SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE profitable?

Yes, SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE generated a net profit of 561 k€ in 2024.

Where is the headquarters of SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE ?

The headquarters of SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE is located in MONTARGIS (45200), in the department Loiret.

Where to find the tax return of SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE ?

The tax return of SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE operate?

SELAS PHARMACIE DU CENTRE COMMERCIAL ET PROFESSIONNEL DE LA CHAUSSEE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.